Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | not detected in single-cell data | 0.00 |
| chemistry Open Targets | a small-molecule pocket: peptide yy human (3-36) | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 200 | 0.91 |
| pathways Reactome | 2 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 16109
Sealed predictions
- NPY2R in dopamine neurons, braak-0.28 (p 0.473) → -0.26 (p 0.500)receipt 16117
Swarm cases
receipt 16117: NPY2R in dopamine neurons, braak
- power
- full sample -0.15 (p 0.549, n 18), 95% CI -0.58 to +0.34. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.18 (p 0.482, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.25 (p 0.315, n 18). could be the mix.
- skeptic
- leave-one-out range -0.28 to -0.06, sign flips 0; without severely affected donors -0.15 (p 0.549, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NPY2R in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts